Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer
Social Anxiety and Avoidance in Head and Neck Cancer Patients
3 other identifiers
observational
100
1 country
2
Brief Summary
RATIONALE: Patients who undergo treatment for head and neck cancer may become anxious and avoid contact with other people. Learning how cancer treatment may cause anxiety in patients with head and neck cancer may help improve the quality of life in these patients. PURPOSE: This clinical trial is studying anxiety and avoidance of others in patients previously treated for head and neck cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2003
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2006
CompletedFirst Submitted
Initial submission to the registry
June 6, 2007
CompletedFirst Posted
Study publicly available on registry
June 7, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2008
CompletedMarch 15, 2013
March 1, 2013
2.3 years
June 6, 2007
March 13, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Level of social anxiety and avoidance in HNC patients post-treatment
Measured by the Liebowitz Social Anxiety Scale and the Social Phobia and Anxiety Inventory, containing 24 items with each item separately rated for fear as 0 (none), 1 (mild), 2 (moderate) to 3 (severe)and for avoidance behavior as 0 (never), 1 (occasionally), 2 (often), to 3 (usually). Scores are summed with lower values indicating lower levels of social anxiety and avoidance.
at study entry, day 1
Secondary Outcomes (3)
Relationship between pre-cancer psychiatric diagnosis and post-treatment social anxiety and avoidance
at study entry
Quality of Life
at study entry, day 1
Comparison of social anxiety and avoidance in patients with head and neck cancer to patients with lung cancer
at study entry, day 1
Interventions
medical chart review
survey administration
management of therapy complications
psychosocial assessment
survey administration
Eligibility Criteria
People who have been treated for head and neck cancer.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Vanderbilt-Ingram Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (2)
MBCCOP - Meharry Medical College - Nashville
Nashville, Tennessee, 37208, United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232-6838, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kirsten Haman, PhD
Vanderbilt-Ingram Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Professor; Psychologist
Study Record Dates
First Submitted
June 6, 2007
First Posted
June 7, 2007
Study Start
November 1, 2003
Primary Completion
March 1, 2006
Study Completion
January 1, 2008
Last Updated
March 15, 2013
Record last verified: 2013-03